Keywords: Parkinson's disease, Market forecasts, Decision Resources, Generic competition

Generics to constrain growth of Parkinson’s disease drug market through 2020

Article | 23 October 2011

Over the next decade, the Parkinson’s disease (PD) drug market in the leading countries (USA, France, Germany, Italy, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in